INHIBITION OF PLATELET PROSTAGLANDIN SYNTHETASE BY ORAL ASPIRIN

被引:515
作者
BURCH, JW [1 ]
STANFORD, N [1 ]
MAJERUS, PW [1 ]
机构
[1] WASHINGTON UNIV, SCH MED, DEPT BIOCHEM, DIV HEMATOL ONCOL, ST LOUIS, MO 63110 USA
关键词
D O I
10.1172/JCI108941
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:314 / 319
页数:6
相关论文
共 43 条
[1]  
ABRAHAMSEN A F, 1968, Scandinavian Journal of Haematology, P1
[2]  
[Anonymous], 1976, J Chronic Dis, V29, P625
[3]  
Baenziger N L, 1974, Methods Enzymol, V31, P149
[4]   CULTURED HUMAN-SKIN FIBROBLASTS AND ARTERIAL CELLS PRODUCE A LABILE PLATELET-INHIBITORY PROSTAGLANDIN [J].
BAENZIGER, NL ;
DILLENDER, MJ ;
MAJERUS, PW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1977, 78 (01) :294-301
[5]   ARTERIAL-WALLS GENERATE FROM PROSTAGLANDIN ENDOPEROXIDES A SUBSTANCE (PROSTAGLANDIN-X) WHICH RELAXES STRIPS OF MESENTERIC AND CELIAC ARTERIES AND INHIBITS PLATELET-AGGREGATION [J].
BUNTING, S ;
GRYGLEWSKI, R ;
MONCADA, S ;
VANE, JR .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1976, 12 (06) :897-913
[6]  
BURCH JW, 1977, CLIN RES, V25, pA513
[7]  
COLLIER JG, 1971, LANCET, V2, P852
[8]  
CORASH L, 1977, BLOOD, V49, P71
[9]   A RANDOMIZED CONTROLLED TRIAL OF ACETYL SALICYLIC ACID IN THE SECONDARY PREVENTION OF MORTALITY FROM MYOCARDIAL INFARCTION [J].
ELWOOD, PC ;
COCHRANE, AL ;
BURR, ML ;
SWEETNAM, PM ;
WILLIAMS, G ;
WELSBY, E ;
HUGHES, SJ ;
RENTON, R .
BRITISH MEDICAL JOURNAL, 1974, 1 (5905) :436-440
[10]   ARTERIAL-WALLS ARE PROTECTED AGAINST DEPOSITION OF PLATELET THROMBI BY A SUBSTANCE (PROSTAGLANDIN-X) WHICH THEY MAKE FROM PROSTAGLANDIN ENDOPEROXIDES [J].
GRYGLEWSKI, RJ ;
BUNTING, S ;
MONCADA, S ;
FLOWER, RJ ;
VANE, JR .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1976, 12 (05) :685-713